Meta-analysis: The risk of venous thromboembolism in patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 10, 2013, Pages 953-962

  Yuhara, H ^a   Steinmaus, C ^b   Corley, D ^c   Koike, J ^a   Igarashi, M ^a   Suzuki, T ^a   Mine, T ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Francisco Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CROHN DISEASE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENTERITIS; HUMAN; LUNG EMBOLISM; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; HUMANS; INFLAMMATORY BOWEL DISEASES; OBESITY; PULMONARY EMBOLISM; RISK FACTORS; SMOKING; VENOUS THROMBOEMBOLISM;

EID: 84876473851     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12294     Document Type: Article

References (51)

1. Heit JA,. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 370-2.
2. Zhan C, Miller MR,. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003; 290: 1868-74.
3. Eikelboom JW, Quinlan DJ, O'Donnell M,. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. Circulation 2009; 120: 2006-11.
4. Longo D, Fauci A, Kasper D, et al,. Harrison's Principles of Internal Medicine, 18th edn. McGraw-Hill Professional, pp. 986-7.
5. Rosendaal FR,. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
6. Novacek G, Haumer M, Schima W, et al,. Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. Inflamm Bowel Dis 2004; 10: 430-5.
7. Jackson LM, O'Gorman PJ, O'Connell J, et al,. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM 1997; 90: 183-8.
8. Murata S, Ishikawa N, Oshikawa S, et al,. Cerebral sinus thrombosis associated with severe active ulcerative colitis. Intern Med 2004; 43: 400-3.
9. Oldenburg B, Fijnheer R, van der Griend R, et al,. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000; 95: 2825-30.
10. Bargen JA, Barker NW,. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58: 17-31.
11. Murthy SK, Nguyen GC,. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 2011; 106: 713-8.
12. Kappelman MD, Horvath-Puho E, Sandler RS, et al,. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011; 60: 937-43.
13. Bernstein CN, Blanchard JF, Houston DS, et al,. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85: 430-4.
14. Miehsler W, Reinisch W, Valic E, et al,. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-8.
15. Bernstein CN, Nabalamba A,. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 2007; 21: 507-11.
16. Nguyen GC, Sam J,. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 2272-80.
17. Nguyen GC, Boudreau H, Harris ML, et al,. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009; 7: 329-34.
18. Grainge MJ, West J, Card TR,. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375: 657-63.
19. Rothberg MB, Lindenauer PK, Lahti M, et al,. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 2012; 147: 120-4.
20. Merrill A, Millham F,. Increased risk of post-operative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of national surgical quality improvement program patients. Arch Surg 2012; 147: 120-4.
21. Saleh T, Matta F, Yaekoub AY, et al,. Risk of venous thromboembolism with inflammatory bowel disease. Clin Appl Thromb Hemost 2011; 17: 254-8.
22. Bröms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H,. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol 2012; 10: 1246-52.
23. Grip O, Svensson PJ, Lindgren S,. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35: 619-23.
24. Samama MM,. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-20.
25. Wang JY, Terdiman JP, Vittinghoff E, Minichiello T, Varma MG,. Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events. World J Gastroenterol 2009; 15: 927-35.
26. Solem CA, Loftus EV, Tremaine WJ, et al,. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99: 97-101.
27. Huerta C, Johansson S, Wallander MA, et al,. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-43.
28. Buchberg B, Masoomi H, Lusby K, et al,. Incidence and risk factors of venous thromboembolism in colorectal surgery: does laparoscopy impart an advantage? Arch Surg 2011; 146: 739-43.
29. Greenland S,. Meta-analysis. In:, Rothman K, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott Raven, 1998; 643-73.
30. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
31. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
33. Egger M, Davey Smith G, Schneider M, et al,. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
34. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
35. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
36. Stouthard JM, Levi M, Hack CE, et al,. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.
37. de Jong E, Porte RJ, Knot EA, et al,. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 1989; 30: 188-94.
38. Zitomersky NL, Verhave M, Trenor CC 3rd,. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. Inflamm Bowel Dis 2011; 17: 458-70.
39. Levi M, van der Poll T, ten Cate H, et al,. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997; 27: 3-9.
40. Devaraj S, Xu DY, Jialal I,. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003; 107: 398-404.
41. Carter MJ, Lobo AJ, Travis SP, IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 (Suppl 5): V1-16.
42. Guyatt GH, Oxman AD, Kunz R, et al,. GRADE Working Group. What is "quality of evidence "and why is it important to clinicians? Br Med J 2008; 336: 995-8.
43. Souto J, Martinez E, Roca M, et al,. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40: 1883-9.
44. Stein PD, Henry JW,. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978-81.
45. Heit JA, Silverstein MD, Mohr DN, et al,. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-53.
46. Righini M, Le Gal G, Aujesky D, et al,. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiorit y t rial. Lancet 2008; 371: 1343-52.
47. Tinsley A, Naymagon S, Trindade AJ, Sachar DB, Sands BE, Ullman TA,. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol 2013; 47: e1-6.
48. Kornbluth A, Sachar DB,. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-23.
49. Mowat C, Cole A, Windsor A, et al,. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607.
50. Travis SP, Stange EF, Lemann M, et al,. European evidencebased consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62.
51. Van Assche G, Dignass A, Reinisch W, et al,. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010; 4: 63-101.